Spectral Medical (TSX:EDT) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:EDT Spectral Medical Inc TSX:EDT
11 GF Score
Price C$1.36
GF Value C$0.92
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Spectral Medical Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSX:EDT vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, Spectral Medical's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spectral Medical Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Short Interest distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Short Interest falls into.


TSX:EDT
11GF Score
Spectral Medical Inc TSX:EDT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Spectral Medical (TSX:EDT) Overvalued in 2026?

Based on GuruFocus' analysis, Spectral Medical stock appears to be overvalued. The current stock price of C$1.36 is trading 47.8% above its estimated GF Value™ of C$0.92. GuruFocus considers Spectral Medical to be Significantly Overvalued.

Key valuation signals for TSX:EDT:

  • Short Interest:
  • GF Value™: C$0.92 vs. price of C$1.36 (47.8% above fair value)
  • GF Score™: 11/100 with 9 warning signs

No single metric tells the full story. See the TSX:EDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spectral Medical Business Description

Other Exchanges EDTXF:USASD4:Germany
Address 135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.
11GF Score

Get the complete analysis for TSX:EDT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.36
Price
C$0.92
GF Value